Asp Isotopes Common Stock Performance
| ASPI Stock | USD 7.74 0.26 3.48% |
The firm shows a Beta (market volatility) of 4.02, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ASP Isotopes will likely underperform. At this point, ASP Isotopes Common has a negative expected return of -0.0293%. Please make sure to confirm ASP Isotopes' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if ASP Isotopes Common performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ASP Isotopes Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, ASP Isotopes is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 3.48 | Five Day Return 6.32 | Year To Date Return 37.48 | Ten Year Return 189.89 | All Time Return 189.89 |
1 | ASP Isotopes Evaluating Valuation Following Capital Raise, Supply Agreement, and Nuclear Medicine Expansion | 10/22/2025 |
2 | Disposition of 67500 shares by Robert Ainscow of ASP Isotopes at 7.507 subject to Rule 16b-3 | 11/17/2025 |
3 | Disposition of 50000 shares by Paul Mann of ASP Isotopes at 5.769 subject to Rule 16b-3 | 11/25/2025 |
4 | Disposition of 162153 shares by Paul Mann of ASP Isotopes at 5.753 subject to Rule 16b-3 | 12/01/2025 |
5 | ASP Isotopes Assessing Valuation Following Revenue Surge and Widening Losses | 12/02/2025 |
6 | ASP Isotopes Chairman Paul Elliot Mann Sells 162,153 Shares | 12/04/2025 |
7 | Disposition of 8438 shares by Robert Ainscow of ASP Isotopes at 6.203 subject to Rule 16b-3 | 12/08/2025 |
8 | Acquisition by Gorley Michael of 36548 shares of ASP Isotopes subject to Rule 16b-3 | 12/18/2025 |
9 | Insider Selling ASP Isotopes CFO Sells 80,000 Shares of Stock | 12/30/2025 |
10 | ASP Isotopes Closes Acquisition of Renergen | 01/07/2026 |
11 | January 2026s Top Growth Stocks With Strong Insider Confidence | 01/14/2026 |
| Begin Period Cash Flow | 7.9 M | |
| Total Cashflows From Investing Activities | -11.4 M |
ASP Isotopes Relative Risk vs. Return Landscape
If you would invest 891.00 in ASP Isotopes Common on October 22, 2025 and sell it today you would lose (117.00) from holding ASP Isotopes Common or give up 13.13% of portfolio value over 90 days. ASP Isotopes Common is currently does not generate positive expected returns and assumes 6.4634% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than ASP, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ASP Isotopes Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ASP Isotopes' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ASP Isotopes Common, and traders can use it to determine the average amount a ASP Isotopes' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0045
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASPI |
Based on monthly moving average ASP Isotopes is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ASP Isotopes by adding ASP Isotopes to a well-diversified portfolio.
ASP Isotopes Fundamentals Growth
ASP Stock prices reflect investors' perceptions of the future prospects and financial health of ASP Isotopes, and ASP Isotopes fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ASP Stock performance.
| Return On Equity | -1.53 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (3.06) % | ||||
| Current Valuation | 968.07 M | ||||
| Shares Outstanding | 125.11 M | ||||
| Price To Book | 13.07 X | ||||
| Price To Sales | 115.51 X | ||||
| Revenue | 4.14 M | ||||
| Gross Profit | 1.93 M | ||||
| EBITDA | (31.58 M) | ||||
| Net Income | (32.33 M) | ||||
| Total Debt | 37.75 M | ||||
| Book Value Per Share | 0.79 X | ||||
| Cash Flow From Operations | (16.7 M) | ||||
| Earnings Per Share | (1.40) X | ||||
| Market Capitalization | 968.35 M | ||||
| Total Asset | 94.35 M | ||||
| Retained Earnings | (56.17 M) | ||||
| Working Capital | 58.69 M | ||||
About ASP Isotopes Performance
By evaluating ASP Isotopes' fundamental ratios, stakeholders can gain valuable insights into ASP Isotopes' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ASP Isotopes has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ASP Isotopes has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 8.48 | 7.54 | |
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (0.27) | (0.29) | |
| Return On Assets | (0.39) | (0.41) | |
| Return On Equity | (0.78) | (0.82) |
Things to note about ASP Isotopes Common performance evaluation
Checking the ongoing alerts about ASP Isotopes for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ASP Isotopes Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ASP Isotopes Common generated a negative expected return over the last 90 days | |
| ASP Isotopes Common has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 4.14 M. Net Loss for the year was (32.33 M) with profit before overhead, payroll, taxes, and interest of 1.93 M. | |
| ASP Isotopes generates negative cash flow from operations | |
| About 17.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Braskem Shares Gap Down Time to Sell |
- Analyzing ASP Isotopes' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ASP Isotopes' stock is overvalued or undervalued compared to its peers.
- Examining ASP Isotopes' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ASP Isotopes' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ASP Isotopes' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ASP Isotopes' stock. These opinions can provide insight into ASP Isotopes' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ASP Stock analysis
When running ASP Isotopes' price analysis, check to measure ASP Isotopes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ASP Isotopes is operating at the current time. Most of ASP Isotopes' value examination focuses on studying past and present price action to predict the probability of ASP Isotopes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ASP Isotopes' price. Additionally, you may evaluate how the addition of ASP Isotopes to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |